Explore a Breakthrough Investment in Alzheimer’s Innovation
Lunch Pail Ventures would like to invite you to our upcoming Investment Event on Thursday, July 24th at 3:00 PM ET, where you will have the opportunity to explore an exciting new investment opportunity at the forefront of medical innovation.
We’re featuring Chuck Papageorgiou, CEO of NeuroEM Therapeutics, a pioneering company addressing one of the most pressing challenges of our time: cognitive decline.
We welcome everyone to join us in-person at Reston Town Center or virtually if you’re unable to attend in person.
If you’ve ever seen a loved one struggle with memory loss or Alzheimer’s, this is an event you won’t want to miss. NeuroEM’s technology is changing the game so significantly that the FDA has awarded it the first-ever “Breakthrough Device” designation for Alzheimer’s.
Join us to hear firsthand how this groundbreaking technology could shape the future of treatment, and how you can be a part of it.
🗓️ Date: Thursday, July 24th
⏰ Time: 3pm ET
📍 In-person: Cooley LLP
11951 Freedom Dr Suite 1400, Reston, VA 20194
💻 Virtual: Zoom (Link to be sent directly)
We look forward to seeing you there!
